Literature DB >> 31453779

Polyoxometalates in Biomedicine: Update and Overview.

Mirjana B Čolović1, Milan Lacković2, Jovana Lalatović3, Ali S Mougharbel4, Ulrich Kortz4, Danijela Z Krstić5.   

Abstract

BACKGROUND: Polyoxometalates (POMs) are negatively charged metal-oxo clusters of early transition metal ions in high oxidation states (e.g., WVI, MoVI, VV). POMs are of interest in the fields of catalysis, electronics, magnetic materials and nanotechnology. Moreover, POMs were shown to exhibit biological activities in vitro and in vivo, such as antitumor, antimicrobial, and antidiabetic.
METHODS: The literature search for this peer-reviewed article was performed using PubMed and Scopus databases with the help of appropriate keywords.
RESULTS: This review gives a comprehensive overview of recent studies regarding biological activities of polyoxometalates, and their biomedical applications as promising anti-viral, anti-bacterial, anti-tumor, and anti-diabetic agents. Additionally, their putative mechanisms of action and molecular targets are particularly considered.
CONCLUSION: Although a wide range of biological activities of Polyoxometalates (POMs) has been reported, they are to the best of our knowledge not close to a clinical trial or a final application in the treatment of diabetes or infectious and malignant diseases. Accordingly, further studies should be directed towards determining the mechanism of POM biological actions, which would enable fine-tuning at the molecular level, and consequently efficient action towards biological targets and as low toxicity as possible. Furthermore, biomedical studies should be performed on solutionstable POMs employing physiological conditions and concentrations. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Polyoxometalates; antibacterial; antitumor; antiviral; biomedicine; normoglycemic activities.

Mesh:

Substances:

Year:  2020        PMID: 31453779     DOI: 10.2174/0929867326666190827153532

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  14 in total

1.  Synthesis and crystal structure of bis-[μ-N,N-bis-(2-amino-eth-yl)ethane-1,2-di-amine]-bis-[N,N-bis-(2-amino-eth-yl)ethane-1,2-di-amine]-μ4-oxido-hexa-μ3-oxido-octa-μ2-oxido-tetra-oxido-tetra-nickel(II)hexa-tantalum(V) nona-deca-hydrate.

Authors:  Dana-Céline Krause; Christian Näther; Wolfgang Bensch
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2021-11-09

2.  Selected polyoxopalladates as promising and selective antitumor drug candidates.

Authors:  Andjelka M Isakovic; Mirjana B Čolović; Tian Ma; Xiang Ma; Marija Jeremic; Marko Gerić; Goran Gajski; Sonja Misirlic-Dencic; Ulrich Kortz; Danijela Krstić
Journal:  J Biol Inorg Chem       Date:  2021-09-21       Impact factor: 3.358

3.  Solution- and gas-phase behavior of decavanadate: implications for mass spectrometric analysis of redox-active polyoxidometalates.

Authors:  Daniel Favre; Cedric E Bobst; Stephen J Eyles; Heide Murakami; Debbie C Crans; Igor A Kaltashov
Journal:  Inorg Chem Front       Date:  2022-02-14       Impact factor: 7.779

4.  Controlled drug delivery and cell adhesion for bone tissue regeneration by Keplerate polyoxometalate (Mo132)/metronidazole/PMMA scaffolds.

Authors:  Hamid Taghiyar; Bahram Yadollahi; Abolghasem Abbasi Kajani
Journal:  Sci Rep       Date:  2022-08-24       Impact factor: 4.996

5.  Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate.

Authors:  Simone Fabbian; Gabriele Giachin; Massimo Bellanda; Christian Borgo; Maria Ruzzene; Giacomo Spuri; Ambra Campofelice; Laura Veneziano; Marcella Bonchio; Mauro Carraro; Roberto Battistutta
Journal:  Front Mol Biosci       Date:  2022-06-02

6.  Metallodrug Profiling against SARS-CoV-2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain-like Protease PLpro.

Authors:  Maria Gil-Moles; Sebastian Türck; Uttara Basu; Andrea Pettenuzzo; Saurav Bhattacharya; Ananthu Rajan; Xiang Ma; Rolf Büssing; Jessica Wölker; Hilke Burmeister; Henrik Hoffmeister; Pia Schneeberg; Andre Prause; Petra Lippmann; Josephine Kusi-Nimarko; Storm Hassell-Hart; Andrew McGown; Daniel Guest; Yan Lin; Anna Notaro; Robin Vinck; Johannes Karges; Kevin Cariou; Kun Peng; Xue Qin; Xing Wang; Joanna Skiba; Łukasz Szczupak; Konrad Kowalski; Ulrich Schatzschneider; Catherine Hemmert; Heinz Gornitzka; Elena R Milaeva; Alexey A Nazarov; Gilles Gasser; John Spencer; Luca Ronconi; Ulrich Kortz; Jindrich Cinatl; Denisa Bojkova; Ingo Ott
Journal:  Chemistry       Date:  2021-11-23       Impact factor: 5.020

7.  Enhancing the biological activity of polyoxometalate-peptide nano-fibrils by spacer design.

Authors:  Valeria Tagliavini; Claudia Honisch; Simona Serratì; Amalia Azzariti; Marcella Bonchio; Paolo Ruzza; Mauro Carraro
Journal:  RSC Adv       Date:  2021-01-26       Impact factor: 3.361

8.  Syntheses, Characterizations, and Inhibition Activities Against Coxsackievirus B3 of Iodobenzoic Hydrazide Functionalized Hexamolybdates.

Authors:  Long-Sheng Wang; Chao Guo; Da Hu; Yan-Xi Zhao; Hui-Hui Liu; Yu-Jia Dong; Shang-Bin Sun; Xing Liu; Kang-Hong Hu; Yan-Hong Wei
Journal:  Front Chem       Date:  2022-03-17       Impact factor: 5.221

9.  In Vitro Antibacterial Susceptibility of Different Pathogens to Thirty Nano-Polyoxometalates.

Authors:  Ștefana Bâlici; Dan Rusu; Emőke Páll; Miuța Filip; Flore Chirilă; Gheorghe Zsolt Nicula; Mihaela Laura Vică; Rodica Ungur; Horea Vladi Matei; Nicodim Iosif Fiț
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-27

10.  Increased in vitro Anti-HIV Activity of Caffeinium-Functionalized Polyoxometalates.

Authors:  Ana G Enderle; Matteo Bosso; Rüdiger Groß; Magdalena Heiland; Mariela Bollini; María J Culzoni; Frank Kirchhoff; Jan Münch; Carsten Streb
Journal:  ChemMedChem       Date:  2021-05-26       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.